Dermatofibroma - Dèrmatofibrom
☆ AI Dermatology — Free Service
Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
Ka tipik Dèrmatofibrom (Dermatofibroma) – yon nodil ki difisil sou manm lan. Dèrmatofibrom (Dermatofibroma) se yon timè benign ki relativman komen.
relevance score : -100.0%
ReferencesDermatofibroma se yon kondisyon po komen ki souvan parèt sou bra oswa janm. Li parèt tankou yon boul fèm anba po a, souvan mwens pase 1 santimèt an dyamèt. Anjeneral li pa fè mal, men li ka asosye ak blesi minè ki te pase, tankou mòde ensèk oswa pike. Dermatofibroma yo ka afekte nenpòt moun, men li pi komen lakay fanm ki gen laj ant 20 ak 40 an. Yo tipikman benign, men pafwa yo ka rekòmanse apre yo fin retire yo. Li enpòtan pou fè diferans ant dermatofibroma ak yon timè po ki pi agresif ki rele dermatofibrosarcoma protuberans.
Dermatofibroma is a commonly occurring cutaneous entity usually centered within the skin's dermis. Dermatofibromas are referred to as benign fibrous histiocytomas of the skin, superficial/cutaneous benign fibrous histiocytomas, or common fibrous histiocytoma. These mesenchymal cell lesions of the dermis clinically are firm subcutaneous nodules that occur on the extremities in the vast majority of cases and may or may not be associated with overlying skin changes. They are most commonly asymptomatic and usually relatively small, less than or equal to 1 centimeter in diameter. Often, patients who present with a dermatofibroma relate a history of possibly inciting local trauma at the site, such as from an insect bite or superficial puncture wound from thorns or wood splinters. Dermatofibromas occur in people of all ages, although more commonly during the ages of the 20s to 40s, and develop more frequently in females than males, with as high as a 2:1 female to male predominance according to some reports. They are a benign tumor, although there have been cases of local recurrence, and even more rarely, distant metastases have been reported. When considering the differential diagnosis of these lesions, it is vitally important to distinguish dermatofibromas from dermatofibrosarcoma protuberans, a similar-appearing but more aggressive cutaneous neoplasm.
Dermatofibroma is a commonly occurring cutaneous entity usually centered within the skin's dermis. Dermatofibromas are referred to as benign fibrous histiocytomas of the skin, superficial/cutaneous benign fibrous histiocytomas, or common fibrous histiocytoma. These mesenchymal cell lesions of the dermis clinically are firm subcutaneous nodules that occur on the extremities in the vast majority of cases and may or may not be associated with overlying skin changes. They are most commonly asymptomatic and usually relatively small, less than or equal to 1 centimeter in diameter. Often, patients who present with a dermatofibroma relate a history of possibly inciting local trauma at the site, such as from an insect bite or superficial puncture wound from thorns or wood splinters. Dermatofibromas occur in people of all ages, although more commonly during the ages of the 20s to 40s, and develop more frequently in females than males, with as high as a 2:1 female to male predominance according to some reports. They are a benign tumor, although there have been cases of local recurrence, and even more rarely, distant metastases have been reported. When considering the differential diagnosis of these lesions, it is vitally important to distinguish dermatofibromas from dermatofibrosarcoma protuberans, a similar-appearing but more aggressive cutaneous neoplasm.
Tretman ki pi souvan pou lipomas, dermatofibromas, keratoacanthomas, pyogenic granulomas, ak epidermoid cysts se retire chirijikalman. Cherry angiomas ak sebaceous hyperplasia souvan trete ak terapi lazè oswa elektrodessikasyon. Kriyoterapi ak eksizyon se chwa popilè pou acrochordons ak seborrheic keratoses. Si yon doktè fanmi pa sèten sou dyagnostik oswa tretman yon blesi, oswa si yon biyopsi konfime melanom, li rekòmande pou refere pasyan an bay yon espesyalis.
The preferred treatment for lipomas, dermatofibromas, keratoacanthomas, pyogenic granulomas, epidermoid cysts is surgical removal. Cherry angiomas, sebaceous hyperplasia are commonly treated with laser therapy or electrodesiccation. Cryotherapy and shave excision are popular choices for acrochordons, seborrheic keratoses. If a family physician feels uncertain about diagnosing or treating a lesion, or if a biopsy confirms melanoma, referral to a specialist is recommended.
The preferred treatment for lipomas, dermatofibromas, keratoacanthomas, pyogenic granulomas, epidermoid cysts is surgical removal. Cherry angiomas, sebaceous hyperplasia are commonly treated with laser therapy or electrodesiccation. Cryotherapy and shave excision are popular choices for acrochordons, seborrheic keratoses. If a family physician feels uncertain about diagnosing or treating a lesion, or if a biopsy confirms melanoma, referral to a specialist is recommended.
Dermatofibromas ka fòme kòm yon reyaksyon a blesi anvan, tankou mòde ensèk oswa pike. Yo klase kòm blesi po benign, sa vle di yo konplètman inofansif, menm si yo ka konfonn ak diferan kalite timè. Dermatofibrom ki gen gwo penetrasyon ka difisil pou distenge, menm sou plan istolojik, de timè fibrohistocytic ra tankou “dermatofibrosarcoma protuberans”.
○ Dyagnostik ak Tretman
Pifò yo se benign, men blesi ki pi gwo (> 5 mm) ka mande byopsi.
#Dermoscopy
#Skin biopsy